Motivation: Chromatin ImmunoPrecipitation followed by Sequencing (ChIPSeq) is used to determine the binding sites of any protein of interest. ChIPSeq data suffer from being more qualitative than quantitative. The recent use of Spikein controls along with the standard protocol tackled this problem. However, no dedicated tool is available for a robust evaluation of this new ChIPseq approach. Results: We developed ChIPSeqSpike, an R/Bioconductor package that enables ChIPSeq spikein normalization, assessment and analysis. Ready to use scaled bigwig files and scaling factors values are obtained as output. ChIPSeqSpike also provides tools for ChIPSeq spikein assessment and analysis through a versatile collection of graphical functions. Availability: The package is implemented in R (as of version 3.4) and is available from Bioconductor at the URL: https://www.bioconductor.org/packages/3.7/bioc/html/ChIPSeqSpike.html, where installation and usage instructions can be found. Contact: nicolas.descostes@nyumc.org
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Introduction
2
Chromatin Immuno-Precipitation followed by Sequencing (ChIP-Seq) is used to determine the chromatin binding sites of any protein of interest, such as transcription factors or histones with or without a specific modification, at a genome scale (Barski et al. 2007; Park 2009 Fig. 1 ).
4
Here we present ChIPSeqSpike, an R/Bioconductor package that provides tools for ChIP-Seq spike-in ChIPSeqSpike normalization, assessment and analysis through a versatile collection of processing and graphical functions.
Features
Data processing
5
The spike-in normalization procedure consists of 4 steps: Read Per Million (RPM) scaling, input DNA subtraction, RPM scaling reversal and exogenous spike-in DNA scaling (Fig. 1A) .
6
The input files consists of BAM and BIGWIG files obtained after alignment on the endogenous and exogenous genome. Input DNA control files are also needed. All normalization steps can be performed independently to offer precision or at once through the usage of the "SpikePipe" wrapping function.
Summary and controls
7
The quality of the experiments can be assessed with the "SpikeSummary" and "getRatio" functions (Fig. 1A) .
8
The first one returns the different scaling factors for each experiment as the number of reads contained in BAM files. The second one assesses the percentage of exogenous DNA relative to the endogenous DNA. This percentage should be in the 2-25% range (Orlando et al. 2014). ChIPSeqSpike throws a warning if this boundary is not met. In theory, having more than 25% exogenous DNA should not affect the normalization whereas having less than 2% is usually not sufficient to perform a reliable normalization. 9
Plots
10
ChIPSeqSpike offers visual assessment of the data with meta-profiles, heatmaps, boxplots, correlation, and heatscatter plots (Fig. 1B) .
11
The data at a particular step of the normalization process can be integrated in a modularity manner and output into publication quality figures. Dedicated options also enable comparison of a same dataset through the different normalization steps described in section 2.1. Finally, ChIPSeqSpike offers versatile graphical options to customize boxplots and correlation plots and also provides the possibility of using different clustering techniques for heatmap representations.
Boost mode
12
Each processing step follows a read and write procedure. Reading and writing BIGWIG and BAM files can be time consuming especially when dealing with large amounts of data. ChIPSeqSpike takes this into account by providing a "boost" mode that keeps data loaded into GRanges objects. This is particularly suitable for users having access to High Performance Computing facilities and wishing to speed up the full workflow.
Conclusion
13 ChIPSeqSpike is to our knowledge the first bioinformatic tool fully dedicated to ChIP-Seq spike-in data normalization. It offers a wide range of possibilities for data processing but also visualization. It offers a fast way to process the data through different modes and provides publication quality figures through a well-defined set of functions. 14 
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